DaviesDA, AdlimoghaddamA, AlbensiBC. The effect of COVID-19 on NF kappa B and neurological manifestations of disease. Mol Neurobiol, 2021; 58(8):4178–4187; doi: 10.1007/s12035-021-02438-2
2.
ChouSH, BeghiE, Helbok, et al. Global incidence of neurological manifestations among patients hospitalized with COVID-19—A report for the GCS-NeuroCOVID consortium and the ENERGY consortium. JAMA Netw Open, 2021; 4(5):e2112131; doi: 10.1001/jamanetworkopen.2021.12131
3.
MeinhardtJ, RadkeJ, DittmayerC, et al.Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci, 2021; 24(2):168–175; doi: 10.1038/s41593-020-00758-5
4.
ChenR, WangK, YuJ, et al.The spatial and cell type distribution of SARS-CoV-2 receptor ACE2 in the human and mouse brains. Front Neurol, 2020; 11:573095; doi: 10.3389/fner.2020.573095
5.
DeDiegoML, Nieto-TorresJL, Regla-NavaJA, et al.Inhibition of NF-kappaB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival. J Virol, 2014; 88(2):913–924; doi: 10.1128/JVI.02576-13
6.
CimminoG, MorelloA, ConteS, et al.Vitamin D inhibits tissue factor and CAMs expression in oxidized low-density lipoproteins-treated human endothelial cells by modulating NF-κB pathway. Eur J Pharmacol, 2020; 885:173422; doi: 10.1016/j.ejphar.2020.173422
7.
MenéndezSG, GiménezVMM, HolickMF, et al.2022. COVID-19 and neurological sequelae: Vitamin D as a possible neuroprotective and/or neuroreparative agent. Life Sci, 2022; 297:120464; doi: 10.1016/j.lfs.2022.120464
8.
WeyhC, KrügerK, PeelingP, et al.The role of minerals in the optimal functioning of the immune system. Nutrients, 2022; 14:644; doi: 10.3390/nu14030644
KhatiwadaS, SubediA. A mechanistic link between selenium and coronavirus disease 2019 (COVID-19). Curr Nutr Rep, 2021; 10(2):125–136; doi: 10.1007/s13668-021-00354-4
11.
Al SulaimanK, AljuhaniO, Al DossariM, et al.Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: A two-center propensity score matched study. Crit Care, 2021; 25:223; doi: 10.1186/s13054-021-03648-9
12.
MahdavifardS, DehghaniR, JeddiF, et al.Thiamine reduced metabolic syndrome symptoms in rats via down-regulation of hepatic nuclear factor-kβ and induction activity of glyoxalase-I. Iran J Basic Med Sci, 2021; 24(3):293–299; doi: 10.22038/ijbms.2021.53707.12086
13.
MarrsC, LonsdaleD. Hiding in plain sight: Modern thiamine deficiency. Cells, 2021; 10:2595; doi: 10.3390/cells10102595
14.
RavulaAR, TeegalaSB, KalakotlaS, et al.Fisetin, potential flavonoid with multifarious targets for treating neurological disorders: An updated review. Eur J Pharmacol, 2021; 910:174492; doi: 10.1016/j.ejphar.2021.174492
15.
CurraisA, PriorM, DarguschR, et al.Modulation of p25 and inflammatory pathways by Fisetin maintains cognitive function in Alzheimer's disease transgenic mice. Aging Cell, 2014; 13(2):379–390; doi: 10.1111/acel.12185
